Showing results (451-460 of 715) with videos related to
Sort By:
Pageof 72
Rheumatology (Oxford, England)|December 16, 2020
Flares in patients with systemic lupus erythematosusKathleen McElhone, Janice Abbott, Margaret Hurley, et al.Nature Communications|July 19, 2024
Tumor detection by analysis of both symmetric- and hemi-methylation of plasma cell-free DNAXu Hua, Hui Zhou, Hui-Chen Wu, et al.The New England Journal of Medicine|December 19, 2019
Trial of Anifrolumab in Active Systemic Lupus ErythematosusEric F Morand, Richard Furie, Yoshiya Tanaka, et al.Nature|January 7, 2016
An ID2-dependent mechanism for VHL inactivation in cancerSang Bae Lee, Veronique Frattini, Mukesh Bansal, et al.Cancers|February 11, 2023
Risk Stratification for Management of Solitary Fibrous Tumor/Hemangiopericytoma of the Central Nervous SystemConnor J Kinslow, Ali I Rae, Prashanth Kumar, et al.The Journal of Clinical Endocrinology and Metabolism|June 4, 2015
Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical TreatmentCarlos M Reyes-Vidal, Hamed Mojahed, Wei Shen, et al.Arthritis Care & Research|January 28, 2016
Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus ErythematosusKathleen McElhone, Janice Abbott, Chris Sutton, et al.Rheumatology (Oxford, England)|May 6, 2021
Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosusRichard A Furie, Ian N Bruce, Thomas Dörner, et al.Journal of the Endocrine Society|April 8, 2020
Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective StudyPamela U Freda, Jeffrey N Bruce, Alexander G Khandji, et al.Tomography (Ann Arbor, Mich.)|July 26, 2018
Monitoring Radiation Treatment Effects in Glioblastoma: FLAIR Volume as Significant Predictor of SurvivalMatthew D Garrett, Ted K Yanagihara, Randy Yeh, et al.Pageof 72